MQR — Multiqure SA Share News
0.000.00%
Last trade - 00:00- PLN342.69m
- PLN292.64m
Brief: Pure Biologics Signs Deal For Running Pre-Clinical Trial In PB004 Project
Brief: Pure Biologics Signs Deal With Customer On Aptamers
Brief: Pure Biologics Signs License Deal For Use Of Pureapta Platform in France
Brief: Pure Biologics Q3 Net Loss Widens To 4.3 Mln Zlotys
Brief: Pure Biologics H1 Net Loss Widens To 6.8 Mln Zlotys
Brief: Pure Biologics Completes First Preclinical Study Under PB001 Project
Brief: Pure Biologics Q1 Net Loss Widens To 3.1 Mln Zlotys
Brief: Pure Biologics FY Net Loss Widens To 11.8 Mln Zlotys
Brief: Pure BiologicsSays European Patent Office Grants Company's Invention Patent
Brief: Filip Jelen Lowers Stake In Pure Biologics To 17.68%
Brief: Filip Jelen Lowers His Stake In Pure Biologics To 22.13%
Brief: WSE To Move Pure Biologics Shares To Main Market On Dec 14
Brief: Aviva Investors FIO, Aviva Investors Specjalistyczny FIO, Aviva Specjalistyczny FIO PPK Up Their Stake In Pure Biologics To 7.56%
Brief: Pure Biologics Says All 0.6 Mln E Series Shares Allocated
Brief: Pure Biologics Sets Price of E Series Shares At 90.0 Zlotys/Shr
Brief: Pure Biologics Signs Deal With Timeline Bioresearch For Pre-Clinical Trial Under PB001 Project
Brief: Pure Biologics Q3 Net Loss Widens To 2.6 Mln Zlotys
Brief: Pure Biologics Gets Second Advance Of 4.0 Mln Zlotys From National Center For R&D
Brief: Pure Biologics KNF Approves Company's Issue Prospectus For Up To 0.6 Mln Shares